|
1
|
Satriano L, Lewinska M, Rodrigues PM,
Banales JM and Andersen JB: Metabolic rearrangements in primary
liver cancers: Cause and consequences. Nat Rev Gastroenterol
Hepatol. 16:748–766. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anwanwan D, Singh SK, Singh S, Saikam V
and Singh R: Challenges in liver cancer and possible treatment
approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harris PS, Hansen RM, Gray ME, Massoud OI,
McGuire BM and Shoreibah MG: Hepatocellular carcinoma surveillance:
An evidence-based approach. World J Gastroenterol. 25:1550–1559.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aldrighetti L, Pulitano C, Catena M, Arru
M, Guzzetti E, Halliday J and Ferla G: Liver resection with portal
vein thrombectomy for hepatocellular carcinoma with vascular
invasion. Ann Surg Oncol. 16:12542009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y
and Jiang X: LncRNA-ATB: An indispensable cancer-related long
noncoding RNA. Cell Prolif. 50:e123812017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen C, Zheng H, Luo Y, Kong Y, An M, Li
Y, He W, Gao B, Zhao Y, Huang H, et al: SUMOylation promotes
extracellular vesicle-mediated transmission of lncRNA ELNAT1 and
lymph node metastasis in bladder cancer. J Clin Invest.
131:e1464312021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin Y, Hou Y, Liu S, Zhu P, Wan X, Zhao M,
Peng M, Zeng H, Li Q, Jin T, et al: A novel long non-coding RNA
lnc030 maintains breast cancer stem cell stemness by stabilizing
SQLE mRNA and increasing cholesterol synthesis. Adv Sci (Weinh).
8:20022322020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang F, Wang H, Yu J, Yao X, Yang S, Li
W, Xu L and Zhao L: LncRNA CRNDE attenuates chemoresistance in
gastric cancer via SRSF6-regulated alternative splicing of PICALM.
Mol Cancer. 20:62021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong X, Yang Z, Yang H, Li D and Qiu X:
Long non-coding RNA MIR4435-2HG promotes colorectal cancer
proliferation and metastasis through miR-206/YAP1 axis. Front
Oncol. 10:1602020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Wu M, Lu Y, He K, Cai X, Yu X, Lu
J and Teng L: LncRNA MIR4435-2HG targets desmoplakin and promotes
growth and metastasis of gastric cancer by activating Wnt/β-catenin
signaling. Aging (Albany NY). 11:6657–6673. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang M, He X, Huang X, Wang J, He Y and
Wei L: LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes
migration and proliferation of nonsmall cell lung cancer cells.
Environ Toxicol. 35:582–590. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen X, Ding Y, Lu F, Yuan H and Luan W:
Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma
proliferation and metastasis through the miR-22-3p/YWHAZ axis. Am J
Transl Res. 12:6381–6394. 2020.PubMed/NCBI
|
|
15
|
Kong Q, Liang C, Jin Y, Pan Y, Tong D,
Kong Q and Zhou J: The lncRNA MIR4435-2HG is upregulated in
hepatocellular carcinoma and promotes cancer cell proliferation by
upregulating miRNA-487a. Cell Mol Biol Lett. 24:262019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Zhang X, Li Z, Wang W, Li B, Huang
X, Sun G, Xu J, Li Q, Xu Z, et al: Circular RNA profile identifies
circOSBPL10 as an oncogenic factor and prognostic marker in gastric
cancer. Oncogene. 38:6985–7001. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han C, Fu Y, Zeng N, Yin J and Li Q:
LncRNA FAM83H-AS1 promotes triple-negative breast cancer
progression by regulating the miR-136-5p/metadherin axis. Aging
(Albany NY). 12:3594–3616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang W, Wang Q, Dai Y, Wang H, Wang M,
Wang J, Zhang D, Sun P, Qi T, Jin X and Cui Z: Hypomethylation of
PlncRNA-1 promoter enhances bladder cancer progression through the
miR-136-5p/Smad3 axis. Cell Death Dis. 11:10382020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Huang C, Zhang A, Lu C and Liu L:
Overexpression of circRNA_100290 promotes the progression of
laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C
axis. Biomed Pharmacother. 125:1098742020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu N, Wu YP, Ke ZB, Liang YC, Cai H, Su
WT, Tao X, Chen SH, Zheng QS, Wei Y and Xue XY: Identification of
key DNA methylation-driven genes in prostate adenocarcinoma: An
integrative analysis of TCGA methylation data. J Transl Med.
17:3112019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kresovich JK, Joyce BT, Gao T, Zheng Y,
Zhang Z, Achenbach CJ, Murphy RL, Just AC, Shen J, Yang H, et al:
Promoter methylation of PGC1A and PGC1B predicts cancer incidence
in a veteran cohort. Epigenomics. 10:733–743. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weisenberger DJ, Liang G and Lenz HJ: DNA
methylation aberrancies delineate clinically distinct subsets of
colorectal cancer and provide novel targets for epigenetic
therapies. Oncogene. 37:566–577. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwok CT, Marshall AD, Rasko JE and Wong
JJ: Genetic alterations of m 6 A regulators predict
poorer survival in acute myeloid leukemia. J Hematol Oncol.
10:392017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fernandes T, Barretti DL, Phillips MI and
Menezes Oliveira E: Exercise training prevents obesity-associated
disorders: Role of miRNA-208a and MED13. Mol Cell Endocrinol.
476:148–154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Correia de Sousa M, Gjorgjieva M, Dolicka
D, Sobolewski C and Foti M: Deciphering miRNAs' action through
miRNA editing. Int J Mol Sci. 20:62492019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klingenberg M, Matsuda A, Diederichs S and
Patel T: Non-coding RNA in hepatocellular carcinoma: Mechanisms,
biomarkers and therapeutic targets. J Hepatol. 67:603–618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang B, Tang D, Zhang Z and Wang Z:
Identification of aberrantly expressed lncRNA and the associated
TF-mRNA network in hepatocellular carcinoma. J Cell Biochem.
121:1491–1503. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J,
Chen J, Liu L, Cai H, Li Z, et al: Knockdown of SOX2OT inhibits the
malignant biological behaviors of glioblastoma stem cells via
up-regulating the expression of miR-194-5p and miR-122. Mol Cancer.
16:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang K, Jin W, Song Y and Fei X: LncRNA
RP11-436H11.5, functioning as a competitive endogenous RNA,
upregulates BCL-W expression by sponging miR-335-5p and promotes
proliferation and invasion in renal cell carcinoma. Mol Cancer.
16:1662017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu S, Zhou J, Sun Y, Li N, Miao M, Jiao B
and Chen H: The noncoding RNA HOXD-AS1 is a critical regulator of
the metastasis and apoptosis phenotype in human hepatocellular
carcinoma. Mol Cancer. 16:1252017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong H, Jian P, Yu M and Wang L: Silencing
of long noncoding RNA LEF1-AS1 prevents the progression of
hepatocellular carcinoma via the crosstalk with
microRNA-136-5p/WNK1. J Cell Physiol. 235:6548–6562. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang W, Shi J, Cheng C and Wang H:
CircTIMELESS regulates the proliferation and invasion of lung
squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis. J Cell
Physiol. 235:5962–5971. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu L, Liu Y, Chen Q, Yu G, Chen J, Chen
K, Yang N, Zeng T, Yan S, Huang A and Tang H: Long-noncoding RNA
colorectal neoplasia differentially expressed gene as a potential
target to upregulate the expression of IRX5 by miR-136-5P to
promote oncogenic properties in hepatocellular carcinoma. Cell
Physiol Biochem. 50:2229–2248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeong HY, Park SY, Kim HJ, Moon S, Lee S,
Lee SH and Kim SH: B3GNT5 is a novel marker correlated with
stem-like phenotype and poor clinical outcome in human gliomas. CNS
Neurosci Ther. 26:1147–1154. 2020. View Article : Google Scholar : PubMed/NCBI
|
